|
Animal Health
(NP #103)
|
|
Development of Improved Diagnostic and Control Strategies for Brucellosis in Livestock and Wildlife
(In-House Appropriated)
|
|
Diagnostic and Mitigation Strategies to Control Tuberculosis in Cattle and Wildlife
(In-House Appropriated)
|
|
Elucidating the Pathobiology and Transmission of Transmissible Spongiform Encephalopathies
(In-House Appropriated)
|
|
Genomic and Mitigation Strategies to Control Mastitis
(In-House Appropriated)
|
|
Host-pathogen Interactions and Control Strategies for Bacterial Respiratory Pathogens in Cattle
(In-House Appropriated)
|
|
Identification of Antigens and Host Innate Immune Responses for Control of Johne's Disease
(In-House Appropriated)
|
|
Intervention Strategies for Spirochete Diseases
(In-House Appropriated)
|
|
Intervention Strategies to Control Endemic and New and Emerging Influenza A Virus Infections in Swine
(In-House Appropriated)
|
|
Intervention Strategies to Control Endemic and New Emerging and Re-Emerging Viral Diseases of Swine
(In-House Appropriated)
|
|
Intervention Strategies to Prevent and Control Viral Respiratory Pathogens of Ruminants
(In-House Appropriated)
|
|
Virulence Mechanisms, Microbiome Changes and Control Strategies for Priority Bacterial Infections in Swine
(In-House Appropriated)
|
|
Continued Development of an Immunological Toolkit and Profile for Bottlenose Dolphins
(Cooperative Agreement)
|
|
Online Algorithms to Identify Reassortment and Genetic Novelty in Genomic Influenza A Virus Surveillance Data
(Cooperative Agreement)
|
|
SARS-CoV-2 White-tailed Deer Infection Dynamics and Antibody Persistence
(Cooperative Agreement)
|
|
Development and Validation of TB Diagnostics for Deer and Cattle that have been Vaccinated with BCG
(Interagency Reimbursable Agreement)
|
|
Development of Vaccines for HPAI in Cattle Related to
HPAI Virus in Food Products (Cattle Studies)
(Interagency Reimbursable Agreement)
|
|
Development of Vaccines for HPAI in Pigs Related to HPAI Virus in Food Products (HPAI Natural Course of Disease)
(Interagency Reimbursable Agreement)
|
|
Development of Vaccines for HPAI in Pigs Related to HPAI Virus in Food Products (Swine Studies)
(Interagency Reimbursable Agreement)
|
|
Experimental Infections of Elk With SARS-CoV-2
(Interagency Reimbursable Agreement)
|
|
Response to APHIS SARS-CoV-2 Research Priorities Phase 1 (VPR)
(Interagency Reimbursable Agreement)
|
|
SARS-CoV-2 White-tailed Deer Infection Dynamics and Antibody Persistence
(Interagency Reimbursable Agreement)
|
|
Severe acute Respiratory Syndrome Coronavirus-2 Research Priorities
(Interagency Reimbursable Agreement)
|
|
TB Diagnostics in Vaccinated Cattle and Deer
(Interagency Reimbursable Agreement)
|
|
The Study of Influenza A Viruses in the Swine Host
(Interagency Reimbursable Agreement)
|
|
The Study of Influenza A Viruses in the Swine Host
(Interagency Reimbursable Agreement)
|
|
USDA Influenza A Virus in Swine Surveillance System – Genomic Epidemiology and Evolution
(Interagency Reimbursable Agreement)
|
|
Assessment of Biochar- Chronic Wasting Disease Interactions and the Feasibility of Using Biochar to Reduce Spread of Chronic Wasting Disease
(Non-Funded Cooperative Agreement)
|
|
Accelerating Bovine Tuberculosis Control in Developing Countries
(Reimbursable Cooperative Agreement)
|
|
Continued Development of an Immunological Toolkit and Profile for Bottlenose Dolphins
(Reimbursable Cooperative Agreement)
|
|
Defining Antagonism Hierarchy of Porcine Epidemic Diarrhea Virus for Live Vaccines Design
(Reimbursable Cooperative Agreement)
|
|
Development and Testing of Mycobacterium Avium Subsp. Paratuberculosis Diva Vaccines in Dairy Cattle
(Reimbursable Cooperative Agreement)
|
|
Development of a Mucosal, Polyanhydride-based Nanoparticle Vaccine for Use Against Respiratory Syncytial Virus Infection in the Neonate
(Reimbursable Cooperative Agreement)
|
|
Mechanisms of Differential Pathogenesis and Risk Among Mammalian Isolates of Highly Pathogenic Avian Influenza A (H5N1) Strains in Swine
(Reimbursable Cooperative Agreement)
|
|
mRNA-LNP Vaccines for Pandemic Preparedness
(Reimbursable Cooperative Agreement)
|
|
NIAID Centers of Excellence for Influenza Research and Response
(Reimbursable Cooperative Agreement)
|
|
Safe and Broadly Cross-Protective Live Attenuated Influenza Virus Vaccine for Use in Swine
(Reimbursable Cooperative Agreement)
|
|
Transmission Bottlenecks and Within-host Evolutionary Dynamics of Influenza A Virus
(Reimbursable Cooperative Agreement)
|
|
Algorithms to Identify Novel Influenza A Viruses in Genomic Surveillance Data
(Non-Assistance Cooperative Agreement)
|
|
Assessing the Potential Transmissibility of Bovine and Cervid Prions with a Human Prion Protein-based Model
(Non-Assistance Cooperative Agreement)
|
|
Characterization of Influenza at the Human and Swine Interface
(Non-Assistance Cooperative Agreement)
|
|
Development of Wireless Sensors for Detecting Misfolded Prion Proteins and Rumen pH of Deer
(Non-Assistance Cooperative Agreement)
|
|
Evaluate ARS Vaccine Candidates Against Mycoplasma Mycoides Subspecies Mycoides
(Non-Assistance Cooperative Agreement)
|
|
Evolution of Influenza A Virus in Swine in Brazil
(Non-Assistance Cooperative Agreement)
|
|
Facilitated Expert Gap Analysis and Review of Contagious Bovine Pleuropneumonia (CBPP)
(Non-Assistance Cooperative Agreement)
|
|
Generation of a Transposon Mutant Library of Mycoplasma Mycoides Subspecies Mycoides
(Non-Assistance Cooperative Agreement)
|
|
Host-pathogen Interactions and Control Strategies for Bacterial Respiratory Pathogens in Cattle
(Non-Assistance Cooperative Agreement)
|
|
Pathogenesis of Swine Acute Diarrhea Syndrome Coronavirus
(Non-Assistance Cooperative Agreement)
|
|
Efficacy of a Pan-genotypic Influenza A Virus Antisense Locked Nucleic Acid Oligonucleotide (LNA) as a Preventative and Therapeutic in Swine
(Trust Fund Cooperative Agreement)
|
|
In Vivo Evaluation of Avirulent Live B. Bronchiseptica Vaccine to Reduce PRDC Severity
(Trust Fund Cooperative Agreement)
|
|
Food Safety, (Animal and Plant Products)
(NP #108)
|
|
Analysis of Genetic Factors that Increase Foodborne Pathogen Fitness, Virulence, and Antimicrobial Resistance Transfer, to Identify Interventions against Salmonella and Campylobacter in Food Animals
(In-House Appropriated)
|
|
Intestinal Microbial Ecology and Non-Antibiotic Strategies to Limit Shiga Toxin-Producing Escherichia coli (STEC) and Antimicrobial Resistance Transmission in Food Animals
(In-House Appropriated)
|
|
Alternatives to Antibiotics: Neonatal Immunomodulation to Improve Disease Resistance in Animals
(Cooperative Agreement)
|
|
Alternatives to Antibiotics: Neonatal Immunomodulation to Improve Disease Resistance in Animals
(Cooperative Agreement)
|
|
Alternatives to Antibiotics: Neonatal Immunomodulation to Improve Disease Resistance in Animals
(Interagency Reimbursable Agreement)
|
|
Development of Vaccines for HPAI in Pigs Related to HPAI Virus in Food Products (HPAI Tissue Distribution)
(Interagency Reimbursable Agreement)
|
|
Precision Bacteriophage Identification Through Machine Learning for Mitigating Persistent Colonization of Shiga Toxin
(Interagency Reimbursable Agreement)
|
|
Development of New Swine Reagents to Broaden Our Understanding of Immune Cell Identity and Function
(Reimbursable Cooperative Agreement)
|
|
Computational Analysis of Host, Bacteria, and Microbiome for Development of Strategies to Enhance Health and Food Safety
(Non-Assistance Cooperative Agreement)
|
|
Revealing Mechanisms for Internal Salmonella Colonization and Persistence in Porcine Lymphoid and Fat Tissues
(Trust Fund Cooperative Agreement)
|
